PLUS THERAPEUTICS, INC. — Director's Dealing 2022

Mar 28, 2022

SEC Form 4/A — Form 4/A

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2021-11-11

Reporting Person: LaFrance Norman D. (CHIEF MEDICAL OFFICER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-11	Stock Option (right to buy shares of common stock)	$1.71	A	120000	Acquired	2031-11-11	Common Stock (120000)	Direct

Footnotes

F1: 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.